Approach to Epistaxis with Systemic Symptoms
Presentation and Initial Investigations
- The American Academy of Otolaryngology-Head and Neck Surgery recommends recognizing epistaxis accompanied by fatigue, palpitations, visual blurring, and tinnitus as a potential hematologic emergency, not a simple nosebleed 1, 2
- Severe thrombocytopenia can cause mucosal bleeding, and profound anemia can result from acute or chronic blood loss, with symptoms such as fatigue and palpitations 2
- Possible bone marrow failure, including aplastic anemia, leukemia, or myelodysplasia, should be considered in patients with epistaxis and systemic symptoms 3
Initial Assessment Priorities
- The American Academy of Otolaryngology-Head and Neck Surgery suggests triaging patients for severity immediately, assessing for hemodynamic instability, which would mandate emergency department evaluation rather than outpatient management 1, 2
- Bleeding duration >30 minutes over 24 hours, bilateral bleeding, or bleeding from the mouth indicates severe epistaxis requiring prompt intervention 1
Investigations to Order and Why
- A complete blood count with differential is essential to determine the pattern of cytopenias, which can indicate isolated thrombocytopenia, pancytopenia, or other conditions 2
- A peripheral blood smear can help exclude acute leukemia, microangiopathic hemolytic anemia, or megaloblastic changes 1
Management Plan with Rationale
- The American Academy of Otolaryngology-Head and Neck Surgery recommends firm, sustained compression to the lower third of the nose for 10-15 minutes without interruption as first-line treatment for epistaxis 2, 3
- Platelet transfusion thresholds are <10,000/μL for prophylactic transfusion and <50,000/μL for therapeutic transfusion in patients with active bleeding 3
- Red blood cell transfusion is indicated if hemoglobin <7 g/dL or if the patient has symptomatic anemia 3
Learning Points
- Epistaxis with systemic symptoms should prompt consideration of hematologic disease, not just an ENT problem 1, 2
- Normal MCV and low reticulocyte count can indicate hypoproliferative anemia, such as aplastic anemia [@General hematology practice]
- Pancytopenia differential diagnosis includes hypocellular marrow (aplastic anemia) and hypercellular marrow (leukemia or MDS) [@General hematology practice]